Pacira Pharmaceuticals (PCRX) Posts Q3 Loss of 49c/Share

November 1, 2012 6:43 AM

Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q3 EPS of ($0.49), $0.05 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found